P01.012 Tumor Treating Fields (TTFields) in combination with lomustine (CCNU) and temozolomide (TMZ) in patients with newly diagnosed glioblastoma (GBM)

INTRODUCTION: TTFields in combination with TMZ showed significant survival benefit for newly diagnosed glioblastoma patients in the EF-14 trial, compared to TMZ standard therapy; independent of MGMT-promotor methylation-status, age and performance status. Recently, the CeTeG trial (NOA-09) demonstra...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Neuro Oncol
Main Authors: Lazaridis, L, Schäfer, N, Kebir, S, Weller, J, Tzaridis, T, Scheffler, B, Pierscianek, D, Kleinschnitz, C, Stuschke, M, Sure, U, Herrlinger, U, Glas, M
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2018
Assuntos:
Poster Presentations
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC6144090/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noy139.054
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares